BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37078808)

  • 1. Dual Functioned Hexapeptide-Coated Lipid-Core Nanomicelles Suppress Toll-Like Receptor-Mediated Inflammatory Responses through Endotoxin Scavenging and Endosomal pH Modulation.
    Ji Y; Sun L; Liu Y; Li Y; Li T; Gong J; Liu X; Ma H; Wang J; Chen B; Fung SY; Yang H
    Adv Sci (Weinh); 2023 Jul; 10(19):e2301230. PubMed ID: 37078808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size-dependent anti-inflammatory activity of a peptide-gold nanoparticle hybrid in vitro and in a mouse model of acute lung injury.
    Gao W; Wang Y; Xiong Y; Sun L; Wang L; Wang K; Lu HY; Bao A; Turvey SE; Li Q; Yang H
    Acta Biomater; 2019 Feb; 85():203-217. PubMed ID: 30597258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Modulatory Activity of Tryptophan Displaying Nanodevices on Macrophage Activation for Preventing Acute Lung Injury.
    Sun L; Wang R; Wu C; Gong J; Ma H; Fung SY; Yang H
    Front Immunol; 2021; 12():750128. PubMed ID: 34659253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of macrophage polarization by peptide-coated gold nanoparticles and its protective effects on acute lung injury.
    Wang L; Zhang H; Sun L; Gao W; Xiong Y; Ma A; Liu X; Shen L; Li Q; Yang H
    J Nanobiotechnology; 2020 Feb; 18(1):38. PubMed ID: 32101146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward A New Targeted Nanotherapy for Acute Lung Injury.
    Sun L; Liu Y; Liu X; Wang R; Gong J; Saferali A; Gao W; Ma A; Ma H; Turvey SE; Fung SY; Yang H
    Adv Sci (Weinh); 2022 Jan; 9(3):e2104051. PubMed ID: 34816630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells.
    Yang H; Kozicky L; Saferali A; Fung SY; Afacan N; Cai B; Falsafi R; Gill E; Liu M; Kollmann TR; Hancock RE; Sly LM; Turvey SE
    Biomaterials; 2016 Dec; 111():90-102. PubMed ID: 27728817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection.
    Dolganiuc A; Norkina O; Kodys K; Catalano D; Bakis G; Marshall C; Mandrekar P; Szabo G
    Gastroenterology; 2007 Nov; 133(5):1627-36. PubMed ID: 17916356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino Acid-Dependent Attenuation of Toll-like Receptor Signaling by Peptide-Gold Nanoparticle Hybrids.
    Yang H; Fung SY; Xu S; Sutherland DP; Kollmann TR; Liu M; Turvey SE
    ACS Nano; 2015 Jul; 9(7):6774-84. PubMed ID: 26083966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation.
    Casey LM; Kakade S; Decker JT; Rose JA; Deans K; Shea LD; Pearson RM
    Biomaterials; 2019 Oct; 218():119333. PubMed ID: 31301576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like Receptor (TLR) Signaling Interacts with CREBH to Modulate High-density Lipoprotein (HDL) in Response to Bacterial Endotoxin.
    Dandekar A; Qiu Y; Kim H; Wang J; Hou X; Zhang X; Zheng Z; Mendez R; Yu FS; Kumar A; Fang D; Sun F; Zhang K
    J Biol Chem; 2016 Oct; 291(44):23149-23158. PubMed ID: 27637329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling.
    Yang H; Fung SY; Bao A; Li Q; Turvey SE
    J Vis Exp; 2017 Jul; (125):. PubMed ID: 28784964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms.
    Zhu Y; Kodvawala A; Hui DY
    Biochem J; 2010 Apr; 428(1):47-54. PubMed ID: 20218969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Anti-inflammatory Activity of Peptide-Gold Nanoparticle Hybrids upon Cigarette Smoke Extract Modification through TLR Inhibition and Autophagy Induction.
    Gao W; Wang L; Wang K; Sun L; Rao Y; Ma A; Zhang M; Li Q; Yang H
    ACS Appl Mater Interfaces; 2019 Sep; 11(36):32706-32719. PubMed ID: 31411854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential roles of S100A10 in Toll-like receptor signaling and immunity to infection.
    Lou Y; Han M; Liu H; Niu Y; Liang Y; Guo J; Zhang W; Wang H
    Cell Mol Immunol; 2020 Oct; 17(10):1053-1062. PubMed ID: 31467414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol.
    Zhu X; Owen JS; Wilson MD; Li H; Griffiths GL; Thomas MJ; Hiltbold EM; Fessler MB; Parks JS
    J Lipid Res; 2010 Nov; 51(11):3196-206. PubMed ID: 20650929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of M1 Macrophage Polarization in Endosomal Toll-Like Receptors Activated Psoriatic Inflammation.
    Lu CH; Lai CY; Yeh DW; Liu YL; Su YW; Hsu LC; Chang CH; Catherine Jin SL; Chuang TH
    Mediators Inflamm; 2018; 2018():3523642. PubMed ID: 30647534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-Like Receptors Drive Specific Patterns of Tolerance and Training on Restimulation of Macrophages.
    Butcher SK; O'Carroll CE; Wells CA; Carmody RJ
    Front Immunol; 2018; 9():933. PubMed ID: 29867935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Regulation of Tolerance to Toll-Like Receptor Ligands in Alveolar Epithelial Cells.
    Neagos J; Standiford TJ; Newstead MW; Zeng X; Huang SK; Ballinger MN
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):872-81. PubMed ID: 25965198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy.
    Broad A; Jones DE; Kirby JA
    Curr Med Chem; 2006; 13(21):2487-502. PubMed ID: 17017906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RM, a novel resveratrol derivative, attenuates inflammatory responses induced by lipopolysaccharide via selectively increasing the Tollip protein in macrophages: A partial mechanism with therapeutic potential in an inflammatory setting.
    Kim WS; Kim K; Byun EB; Song HY; Han JM; Park WY; Yuk JM; Byun EH
    Int Immunopharmacol; 2020 Jan; 78():106072. PubMed ID: 31835082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.